“The Russian Ministry of Health has registered two antiviral drugs remdesivir for the treatment of new coronavirus infection (COVID-19).
Registration certificates for domestic and imported drugs were issued on Wednesday, ”the ministry said in a statement.
Earlier, FMBA patented a drug for the treatment of coronavirus infection, which "turns off the activity" of COVID-19 and "kills" it.
On August 6, the FMBA announced that they received a patent for the drug Leitragin, which can prevent or mitigate complications caused by COVID-19.